The Shifting Field of Stem Cell Regulations
Recent FDA Hearings Sparked by Concerns Over Growth of Clinics Offering Unapproved Therapies to Consumers
Enhancing Graduate and Postdoc Education for a Sustainable Workforce
Ph.D.-Trained Biomedical Scientists Can No Longer Count on Finding Academic Positions Upon Graduation
Unlucky 13: Top Clinical Trial Failures of 2016
In Missing Primary Endpoints, These Drugs Touched Off Stock Selloff, Layoffs, and Worse
Supplement: Therapeutic Cancer Vaccine Roundup
Individualized Cell Therapies Come with a Unique Set of Bioprocess Requirements
For full access to this article login to GEN Select now.
Surmounting siRNA Delivery Obstacles
Nanoparticle Carriers and Noninvasive Methods Are Among Recent Advances
- Despite considerable challenges, RNA interference (RNAi) as a therapeutic strategy continues to draw excitement and scrutiny. Two recent meetings—Select Biosciences’ “RNAi and miRNA World Congress” and “RNAi 2010”—provided updates on the field. A number of presentations focused on advances in the use of major players in silencing the double-stranded ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.